tiprankstipranks
Trending News
More News >
My Size Inc (MYSZ)
NASDAQ:MYSZ
Advertisement

My Size (MYSZ) AI Stock Analysis

Compare
435 Followers

Top Page

MYSZ

My Size

(NASDAQ:MYSZ)

Rating:48Neutral
Price Target:
$1.00
▼(-17.36% Downside)
The overall stock score is primarily influenced by financial performance, which highlights strong revenue growth but persistent profitability challenges. Technical analysis indicates a bearish trend with neutral momentum, while valuation metrics are weak due to negative earnings and lack of dividends. These factors collectively suggest caution for potential investors.
Positive Factors
Market Adoption
My Size's unique sizing software, not reliant on privacy damaging cameras, should continue to see greater market exposure.
Operating Efficiency
The sequential improvement in gross margin to 49.7%, up from March's 40.1%, embodies the efficiency gains My Size has fashioned in Orgad's operation.
Revenue Growth
Sequential gain in SaaS revenue to $172,000, up from 2Q24's $163,000, signaling continued interest in My Size solutions.
Negative Factors
Industry Challenges
The software fitting business is a struggle for all participants across the industry primarily on account of retailers' skimpy margins and reluctance to make performance enhancing investment.
Investment Risks
Risks associated with a My Size investment include future dilution while others are latent in the marketing, sale, and adoption of MySizeID.
Revenue Decline
Sales of $1.8M, down 7% sequentially from June's $2.0M, the second consecutive sequential decline, and down 14% year over year from $2.2M.

My Size (MYSZ) vs. SPDR S&P 500 ETF (SPY)

My Size Business Overview & Revenue Model

Company DescriptionMy Size, Inc. develops and commercializes mobile device measurement solutions for e-commerce fashion/apparel, shipping/parcel, and do it yourself industries in Israel. It offers MySizeID, an application that enables consumers to create an online profile of their personal measurements to get the right fit; BoxSize, a parcel measurement application that allows customers to measure the size of their parcel with their smartphone, calculate shipping costs, and arrange for a convenient pick-up time for the package; SizeUp app, which allows users to utilize their smartphone as a tape measure; and SizeIT, a smart measuring tape SDK that provides users with the ability to instantly and accurately measure objects with a quick movement of their mobile device. The company was formerly known as Knowledgetree Ventures, Inc. and changed its name to My Size, Inc. in January 2014. My Size, Inc. was incorporated in 1999 and is headquartered in Airport City, Israel.
How the Company Makes MoneyMy Size generates revenue primarily through its subscription-based model and licensing agreements with retailers and e-commerce platforms. The company charges retailers for access to its sizing and fit technology, which they can integrate into their online stores. Additionally, My Size earns revenue from sales of its mobile applications directly to consumers, who may pay for premium features. Significant partnerships with major retail brands and platforms enhance its market reach and drive sales, while ongoing advancements in technology and customer engagement strategies contribute to its earnings.

My Size Financial Statement Overview

Summary
My Size has demonstrated strong revenue growth over recent years, yet it continues to face profitability challenges with sustained net losses. The balance sheet is stable with low leverage, but cash flow issues persist, highlighting the need for improved operational efficiency and cost management to ensure long-term sustainability.
Income Statement
45
Neutral
The company has shown significant revenue growth, increasing from $63,000 in 2019 to $8,257,000 in 2024. However, despite the revenue growth, the company remains unprofitable with a net loss of $3,995,000 in 2024. Gross profit margin improved to 40.24% in 2024, but the persistent net losses and negative EBIT and EBITDA margins highlight ongoing challenges in achieving profitability.
Balance Sheet
60
Neutral
The balance sheet shows a strong equity position with equity increasing to $6,909,000 in 2024. The debt-to-equity ratio is low at 0.04, indicating minimal leverage. However, the company has been burning cash with significant net losses, which could pressure its cash reserves over time.
Cash Flow
40
Negative
The company has consistently negative operating cash flows, with a free cash flow of -$3,099,000 in 2024, indicating reliance on external financing. Although there has been some improvement in free cash flow, the negative operating cash flow to net income ratio suggests operational inefficiencies.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.78M8.26M7.00M4.46M131.00K142.00K
Gross Profit2.69M3.32M2.73M634.00K131.00K140.00K
EBITDA-3.15M-3.00M-5.10M-8.09M-10.44M-6.07M
Net Income-3.52M-4.00M-6.38M-8.31M-10.52M-6.17M
Balance Sheet
Total Assets9.86M10.06M8.99M9.73M12.56M3.57M
Cash, Cash Equivalents and Short-Term Investments4.28M4.88M2.19M2.10M10.67M1.69M
Total Debt189.00K276.00K694.00K998.00K611.00K708.00K
Total Liabilities2.45M3.15M4.26M5.19M1.70M1.49M
Stockholders Equity7.41M6.91M4.74M4.54M10.86M2.08M
Cash Flow
Free Cash Flow-3.36M-3.10M-6.11M-7.32M-7.32M-5.72M
Operating Cash Flow-3.33M-3.09M-6.11M-7.29M-7.30M-5.68M
Investing Cash Flow-61.00K53.00K-7.00K-993.00K161.00K-211.00K
Financing Cash Flow4.52M5.59M6.13M-67.00K16.29M6.09M

My Size Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.21
Price Trends
50DMA
1.25
Negative
100DMA
1.26
Negative
200DMA
1.59
Negative
Market Momentum
MACD
-0.02
Positive
RSI
47.26
Neutral
STOCH
39.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MYSZ, the sentiment is Negative. The current price of 1.21 is below the 20-day moving average (MA) of 1.22, below the 50-day MA of 1.25, and below the 200-day MA of 1.59, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 47.26 is Neutral, neither overbought nor oversold. The STOCH value of 39.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MYSZ.

My Size Risk Analysis

My Size disclosed 57 risk factors in its most recent earnings report. My Size reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

My Size Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$35.62B7.50-10.94%1.87%8.86%-10.27%
48
Neutral
$3.81M-53.78%-31.86%90.11%
$7.63M-79.06%
41
Neutral
$10.08M-127.98%-53.98%72.82%
$5.41M-198.73%
48
Neutral
$7.02M-247.72%0.31%70.95%
39
Underperform
$7.47M-575.54%-28.60%-294.74%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MYSZ
My Size
1.21
-0.74
-37.95%
FTFT
Future FinTech Group
2.28
-1.21
-34.67%
OLB
OLB Group
1.13
-1.19
-51.29%
AUUD
Auddia
2.41
-12.21
-83.52%
SOPA
Society Pass
1.32
0.29
28.16%
IDAI
T Stamp, Inc. Class A
2.90
-1.85
-38.95%

My Size Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
My Size Adjusts Stock Options Exercise Price
Neutral
Jun 6, 2025

On June 4, 2025, My Size, Inc. adjusted the exercise price of stock options for certain employees, officers, and directors, lowering it to $1.28 per share, aligning with the closing price on that date. This adjustment affected options for 13,926 shares, including those held by key executives such as CEO Ronen Luzon and former CFO Or Kles. Additionally, the company accelerated the vesting of 18,750 restricted shares for Mr. Kles, recognizing his service, making them fully vested as of his termination on March 31, 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 15, 2025